Table 4. Summary of the number of DE genes which were found to be Network and Function eligible using Ingenuity Pathway Analysis (IPA) in comparison of control vs. infected of different tissues.
| Comparison (control vs Infected) |
Number of DE genes* |
Ingenuity Pathway Analysis |
||
|---|---|---|---|---|
| Mapped IDs | Network eligible | Functions eligible | ||
| Brain |
152 |
82 |
77 |
77 |
| Midbrain |
66 |
27 |
22 |
24 |
| Thalamus |
11 |
73 |
69 |
66 |
| Spleen |
249 |
145 |
124 |
123 |
| RPLN |
30 |
15 |
14 |
14 |
| Tonsil | 55 | 29 | 23 | 22 |
*
DE genes were determined using Genesifter analysis.